查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1948369

2026年全球结核病诊断市场报告

Tuberculosis Diagnostics Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，结核病诊断市场显着扩张，预计将从2025年的23.4亿美元成长到2026年的25.2亿美元，复合年增长率为7.9%。过去几年的成长可归因于多种因素，例如全球结核病负担加重、公共卫生筛检计画的扩展、涂片显微镜基础设施的建设、国际社会对结核病控制的投入以及基于培养的诊断方法的采用。

预计未来几年结核病诊断市场规模将强劲成长，2030年将达到33.7亿美元，复合年增长率（CAGR）为7.5%。预测期内的成长可归因于以下因素：对快速、准确的结核病诊断需求不断增长、对抗药性结核病检测的日益重视、分散式诊断检测的扩展、分子诊断投资的增加以及人工智慧辅助诊断工具的整合。预测期内的主要趋势包括：分子结核病检测的日益普及、快速诊断平台的广泛应用、抗药性检测的日益整合、照护现场检测的扩展以及对高灵敏度诊断的日益重视。

结核病（TB）发病率的不断上升预计将持续推动对结核病诊断的需求。结核病是一种高度传染性的细菌感染疾病，主要侵袭肺部，需要快速识别以防止严重的健康併发症和进一步传播。结核病负担日益加重主要是由于爱滋病毒/爱滋病疫情的蔓延，爱滋病毒/爱滋病会削弱免疫系统，并显着增加罹患活动性结核病的风险。发病率的上升促使人们需要快速、准确的就地检验，并采用能够儘早启动治疗和改善疾病管理的结核病诊断解决方案。例如，根据英国卫生安全局（负责英格兰卫生安全的政府机构）于2025年10月发布的报告，2024年英格兰的结核病病例数将同比增长13.6%，达到5490例（上一年为4831例）。因此，结核病发病率的上升正在推动结核病诊断市场的扩张。

结核病诊断领域的主要企业正优先考虑产品创新和先进诊断解决方案的开发，以巩固其市场地位。结核病诊断测试包括各种医学评估和实验室方法，用于确定受检者是否感染了结核分枝桿菌（即引起结核病的细菌）。这些测试对于识别活动性结核病、潜伏性感染和抗药性菌株至关重要，从而能够及时采取适当的检查室治疗性介入。例如，2023年2月，总部位于印度的技术主导诊断服务供应商Redcliffe Labs推出了BD MAX MDR TB Test，这是一种旨在作为第一线检测方案的诊断解决方案，可帮助临床医生快速检测结核病和多重抗药性。此测试在BD MAX分子诊断系统上运行，可同时检测结核病致病菌并识别与第一线药物异烟肼（INH）和利福平（RIF）抗药性相关的基因突变。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球结核病诊断市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 物联网、智慧基础设施和互联生态系统
    • 人工智慧（AI）和自主人工智慧
  • 主要趋势
    • 扩大结核病分子检测的应用
    • 快速诊断平台的使用日益增多
    • 药物抗药性检测技术的整合正在取得进展
    • 扩大照护现场
    • 人们对高灵敏度诊断的兴趣日益浓厚

第五章 终端用户产业市场分析

  • 医院和诊断检查室
  • 参考检查室
  • 公共卫生机构
  • 医生办公室检查室
  • 研究所

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球结核病诊断市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球结核病诊断市场规模、对比及成长率分析
  • 全球结核病诊断市场表现：规模与成长，2020-2025年
  • 全球结核病诊断市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场总量（TAM）

第九章 市场细分

  • 按测试类型
  • 放射线检查、核酸检查、细胞激素检测、抗药性检测、皮肤试验/结核菌素试验（TST）、血液/血清学检查、涂片显微镜检查、细胞培养试验及其他类型的检测
  • 按疾病阶段
  • 潜伏性结核病，活动性结核病
  • 最终用户
  • 医院与诊断检查室、诊所检查室、参考检查室、学术研究机构
  • 按类型细分：放射摄影
  • 胸部X光片、 电脑断层扫描
  • 按类型细分：核酸检测
  • 聚合酵素链锁反应（PCR）、核酸增幅检查（NAAT）
  • 按类型细分：细胞激素检测
  • 干扰素-γ释放试验（IGRA）
  • 按类型细分：抗药性检测
  • GeneXpert MTB/RIF 线性探针检测
  • 按类型细分：皮肤测试/一对一测试 (TST)
  • 结核菌素皮肤试验（TST）
  • 按类型细分：血液和血清检测
  • 抗体血清学检测
  • 按类型细分：涂片显微镜
  • 抗酸桿菌（AFB）涂片检查
  • 按类型细分：基于细胞培养的检测
  • 固体培养基培养、液体培养基培养
  • 按类型细分：其他测试类型
  • 分子检测、先进影像诊断技术

第十章 区域与国家分析

  • 全球结核病诊断市场：区域表现及预测，2020-2025年、2025-2030年预测、2035年预测
  • 全球结核病诊断市场：国家、绩效及预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 结核病诊断市场：竞争格局与市场占有率（2024 年）
  • 结核病诊断市场：公司估值矩阵
  • 结核病诊断市场：公司概况
    • Beckton, Dickinson and Company
    • F. Hoffmann-La Roche Ltd
    • Qiagen NV
    • BioMerieux SA
    • Danaher Corporation

第37章：其他领先和创新企业

  • PerkinElmer, Thermo Fisher Scientific Inc., Creative Diagnostics, Lionex GmbH, Biocartis, Bio-Rad Laboratories India Pvt. Ltd, Zhejiang Di'an Diagnostics Technology Co., Ltd, Kindstar Global, Siemens AG, LumiraDx Limited, TestLine Clinical Diagnostics sro, Hologic, Meridian Bioscience, Abbott Laboratories Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年结核病诊断市场：提供新机会的国家
  • 2030年结核病诊断市场：充满新机会的细分市场
  • 2030年结核病诊断市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME5MTDIA02_G26Q1

Tuberculosis diagnostics encompass tools or tests characterized by high sensitivity and specificity in diagnosing TB and monitoring treatment effectiveness. They aim to identify acid-fast bacilli (AFB) in clinical samples and detect tuberculosis.

The tuberculosis diagnostics market comprises various types of tests such as radiographic testing, laboratory testing, nucleic acid testing, cytokine detection testing, drug resistance testing, skin test (TST)/Mantoux test, blood/serology tests, smear microscopy tests, cell culture-based tests, and other methods. Radiographic tests are utilized to identify chest abnormalities indicative of tuberculosis symptoms. These tests focus on diagnosing lesions that can manifest anywhere in the lungs, differing in cavitation, density, size, and shape. These diagnostic methods encompass nucleic acid testing (NAT), skin testing or Mantoux test (TST), blood testing or serology tests, smear microscopy, cultured-based tests, radiography tests, and other approaches. They serve various disease stages such as latent tuberculosis and active tuberculosis. End-users of tuberculosis diagnostics include hospitals, diagnostic laboratories, physician's office laboratories, reference laboratories, academic institutions, and research facilities.

Tariffs are impacting the tuberculosis diagnostics market by increasing costs of imported reagents, diagnostic kits, molecular testing instruments, imaging components, and laboratory consumables. Public health systems and diagnostic laboratories in low- and middle-income regions are most affected due to dependence on imported testing supplies, while developed markets face higher equipment costs. These tariffs are raising testing expenses and affecting screening coverage. However, they are also encouraging local manufacturing of diagnostic kits, regional reagent production, and technology transfer initiatives supporting long-term diagnostic capacity building.

The tuberculosis diagnostics market research report is one of a series of new reports from The Business Research Company that provides tuberculosis diagnostics market statistics, including tuberculosis diagnostics industry global market size, regional shares, competitors with a tuberculosis diagnostics market share, detailed tuberculosis diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the tuberculosis diagnostics industry. This tuberculosis diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tuberculosis diagnostics market size has grown strongly in recent years. It will grow from $2.34 billion in 2025 to $2.52 billion in 2026 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to global tuberculosis disease burden, expansion of public health screening programs, availability of smear microscopy infrastructure, international funding for tb control, adoption of culture-based diagnostics.

The tuberculosis diagnostics market size is expected to see strong growth in the next few years. It will grow to $3.37 billion in 2030 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to growing demand for rapid and accurate tb diagnosis, rising focus on drug-resistant tb detection, expansion of decentralized diagnostic testing, increasing investments in molecular diagnostics, integration of ai-assisted diagnostic tools. Major trends in the forecast period include increasing adoption of molecular tb testing methods, rising use of rapid diagnostic platforms, growing integration of drug resistance detection, expansion of point-of-care tb testing, enhanced focus on high-sensitivity diagnostics.

The increasing incidence of tuberculosis is expected to drive demand for tuberculosis diagnostics going forward. Tuberculosis (TB) is a highly contagious bacterial infection that primarily affects the lungs and requires prompt identification to prevent serious health complications and further transmission. The growing burden of tuberculosis is largely attributed to the rising prevalence of HIV/AIDS, which weakens the immune system and significantly increases susceptibility to developing active TB disease. This rising incidence is supporting the adoption of tuberculosis diagnostic solutions by increasing the need for rapid, accurate, and point-of-care testing that enables early initiation of treatment and improved disease management. For instance, in October 2025, according to the UK Health Security Agency, a government body responsible for health security in England, tuberculosis cases in England rose by 13.6 percent in 2024 compared to 2023, with 5,490 reported cases in 2024 versus 4,831 cases in the previous year. Therefore, the growing incidence of tuberculosis is contributing to the expansion of the tuberculosis diagnostics market.

Leading companies operating in the tuberculosis diagnostics space are prioritizing product innovation and the development of advanced diagnostic solutions to strengthen their market presence. Tuberculosis diagnostic tests include a range of medical assessments and laboratory methods used to determine whether an individual is infected with Mycobacterium tuberculosis, the bacterium responsible for TB. These tests are critical for identifying active tuberculosis, latent infections, and drug-resistant strains, allowing timely and appropriate treatment interventions. For example, in February 2023, Redcliffe Labs, an India-based technology-enabled diagnostics service provider, launched the BD MAX MDR TB test, a diagnostic solution designed to help clinicians rapidly detect tuberculosis and multidrug resistance as a first-line test. Conducted on the BD MAX molecular diagnostic system, the test enables simultaneous detection of TB-causing bacteria and identification of genetic mutations associated with resistance to two key first-line drugs, isoniazid (INH) and rifampicin (RIF).

In August 2023, Danaher Corporation, a US-based science and technology company, acquired Abcam plc for approximately $24.00 per share, totaling over $5.7 billion. This acquisition aims to bolster Danaher Corporation's position in the life sciences sector by utilizing Abcam plc's extensive portfolio of high-quality reagents and antibodies. This will enhance Danaher's capabilities in scientific research and development, allowing it to better meet the growing demand for advanced biological research tools. Abcam plc, a UK-based biotechnology company, also provides tuberculosis diagnostics.

Major companies operating in the tuberculosis diagnostics market are Beckton Dickinson and Company, F. Hoffmann-La Roche Ltd, Qiagen N.V, BioMerieux SA, Danaher Corporation, PerkinElmer, Thermo Fisher Scientific Inc., Creative Diagnostics, Lionex GmbH, Biocartis, Bio-Rad Laboratories India Pvt.Ltd, Zhejiang Di'an Diagnostics Technology Co. Ltd, Kindstar Global, Siemens AG, LumiraDx Limited, TestLine Clinical Diagnostics s.r.o., Hologic, Meridian Bioscience, Abbott Laboratories Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc, Akonni Biosystems Inc, Epistem Limited, Gen-Probe, Bio Certica, BixBio

Asia-Pacific was the largest region in the tuberculosis diagnostics market in 2025. The regions covered in the tuberculosis diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tuberculosis diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The tuberculosis diagnostics market includes revenues earned by entities by providing services related to diagnostic laboratory methods, detection of latent infection, detection of drug resistance, and diagnostic laboratory testings. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tuberculosis Diagnostics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses tuberculosis diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tuberculosis diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The tuberculosis diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Test Type: Radiographic Tests; Nucleic Acid Testing; Cytokine Detection Tests; Drug Resistance Tests; Skin Test / Mantoux Test (TST); Blood/Serology Test; Smear Microscopy Tests; Cell Culture-Based Tests; Other Test Types
  • 2) By Disease Stage: Latent Tuberculosis; Active Tuberculosis
  • 3) By End-User: Hospitals And Diagnostic Laboratories; Physician's Office Laboratories; Reference Laboratories; Academics And Research Facilities
  • Subsegments:
  • 1) By Radiographic Tests: Chest X-rays; CT Scans
  • 2) By Nucleic Acid Testing: Polymerase Chain Reaction (PCR); Nucleic Acid Amplification Tests (NAATs)
  • 3) By Cytokine Detection Tests: Interferon Gamma Release Assays (IGRAs)
  • 4) By Drug Resistance Tests: GeneXpert MTB/RIF; Line Probe Assays
  • 5) By Skin Test or Mantoux Test (TST): Tuberculin Skin Test (TST)
  • 6) By Blood Or Serology Test: Serological Tests for Antibodies
  • 7) By Smear Microscopy Tests: Acid-Fast Bacilli (AFB) Smear Test
  • 8) By Cell Culture-Based Tests: Solid Media Cultures; Liquid Media Cultures
  • 9) By Other Test Types: Molecular Tests; Advanced Imaging Techniques
  • Companies Mentioned: Beckton Dickinson and Company; F. Hoffmann-La Roche Ltd; Qiagen N.V; BioMerieux SA; Danaher Corporation; PerkinElmer; Thermo Fisher Scientific Inc.; Creative Diagnostics; Lionex GmbH; Biocartis; Bio-Rad Laboratories India Pvt.Ltd; Zhejiang Di'an Diagnostics Technology Co. Ltd; Kindstar Global; Siemens AG; LumiraDx Limited; TestLine Clinical Diagnostics s.r.o.; Hologic; Meridian Bioscience; Abbott Laboratories Immunodiagnostic Systems Holdings PLC; Mesa Biotech Inc; Akonni Biosystems Inc; Epistem Limited; Gen-Probe; Bio Certica; BixBio
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Tuberculosis Diagnostics Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Tuberculosis Diagnostics Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Tuberculosis Diagnostics Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Tuberculosis Diagnostics Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Artificial Intelligence & Autonomous Intelligence
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Molecular Tb Testing Methods
    • 4.2.2 Rising Use Of Rapid Diagnostic Platforms
    • 4.2.3 Growing Integration Of Drug Resistance Detection
    • 4.2.4 Expansion Of Point-Of-Care Tb Testing
    • 4.2.5 Enhanced Focus On High-Sensitivity Diagnostics

5. Tuberculosis Diagnostics Market Analysis Of End Use Industries

  • 5.1 Hospitals And Diagnostic Laboratories
  • 5.2 Reference Laboratories
  • 5.3 Public Health Institutions
  • 5.4 Physician'S Office Laboratories
  • 5.5 Research Institutes

6. Tuberculosis Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Tuberculosis Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Tuberculosis Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Tuberculosis Diagnostics Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Tuberculosis Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Tuberculosis Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Tuberculosis Diagnostics Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Tuberculosis Diagnostics Market Segmentation

  • 9.1. Global Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Radiographic Tests, Nucleic Acid Testing, Cytokine Detection Tests, Drug Resistance Tests, Skin Test / Mantoux Test (TST), Blood/Serology Test, Smear Microscopy Tests, Cell Culture-Based Tests, Other Test Types
  • 9.2. Global Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Latent Tuberculosis, Active Tuberculosis
  • 9.3. Global Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Diagnostic Laboratories, Physician's Office Laboratories, Reference Laboratories, Academics And Research Facilities
  • 9.4. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Radiographic Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Chest X-rays, CT Scans
  • 9.5. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Nucleic Acid Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polymerase Chain Reaction (PCR), Nucleic Acid Amplification Tests (NAATs)
  • 9.6. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Cytokine Detection Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Interferon Gamma Release Assays (IGRAs)
  • 9.7. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Drug Resistance Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • GeneXpert MTB/RIF, Line Probe Assays
  • 9.8. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Skin Test / Mantoux Test (TST), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Tuberculin Skin Test (TST)
  • 9.9. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Blood/Serology Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Serological Tests for Antibodies
  • 9.10. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Smear Microscopy Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Acid-Fast Bacilli (AFB) Smear Test
  • 9.11. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Cell Culture-Based Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Solid Media Cultures, Liquid Media Cultures
  • 9.12. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Molecular Tests, Advanced Imaging Techniques

10. Tuberculosis Diagnostics Market Regional And Country Analysis

  • 10.1. Global Tuberculosis Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Tuberculosis Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Tuberculosis Diagnostics Market

  • 11.1. Asia-Pacific Tuberculosis Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Tuberculosis Diagnostics Market

  • 12.1. China Tuberculosis Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Tuberculosis Diagnostics Market

  • 13.1. India Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Tuberculosis Diagnostics Market

  • 14.1. Japan Tuberculosis Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Tuberculosis Diagnostics Market

  • 15.1. Australia Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Tuberculosis Diagnostics Market

  • 16.1. Indonesia Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Tuberculosis Diagnostics Market

  • 17.1. South Korea Tuberculosis Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Tuberculosis Diagnostics Market

  • 18.1. Taiwan Tuberculosis Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Tuberculosis Diagnostics Market

  • 19.1. South East Asia Tuberculosis Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Tuberculosis Diagnostics Market

  • 20.1. Western Europe Tuberculosis Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Tuberculosis Diagnostics Market

  • 21.1. UK Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Tuberculosis Diagnostics Market

  • 22.1. Germany Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Tuberculosis Diagnostics Market

  • 23.1. France Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Tuberculosis Diagnostics Market

  • 24.1. Italy Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Tuberculosis Diagnostics Market

  • 25.1. Spain Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Tuberculosis Diagnostics Market

  • 26.1. Eastern Europe Tuberculosis Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Tuberculosis Diagnostics Market

  • 27.1. Russia Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Tuberculosis Diagnostics Market

  • 28.1. North America Tuberculosis Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Tuberculosis Diagnostics Market

  • 29.1. USA Tuberculosis Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Tuberculosis Diagnostics Market

  • 30.1. Canada Tuberculosis Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Tuberculosis Diagnostics Market

  • 31.1. South America Tuberculosis Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Tuberculosis Diagnostics Market

  • 32.1. Brazil Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Tuberculosis Diagnostics Market

  • 33.1. Middle East Tuberculosis Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Tuberculosis Diagnostics Market

  • 34.1. Africa Tuberculosis Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Tuberculosis Diagnostics Market, Segmentation By Test Type, Segmentation By Disease Stage, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Tuberculosis Diagnostics Market Regulatory and Investment Landscape

36. Tuberculosis Diagnostics Market Competitive Landscape And Company Profiles

  • 36.1. Tuberculosis Diagnostics Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Tuberculosis Diagnostics Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Tuberculosis Diagnostics Market Company Profiles
    • 36.3.1. Beckton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Qiagen N.V Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. BioMerieux SA Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Tuberculosis Diagnostics Market Other Major And Innovative Companies

  • PerkinElmer, Thermo Fisher Scientific Inc., Creative Diagnostics, Lionex GmbH, Biocartis, Bio-Rad Laboratories India Pvt. Ltd, Zhejiang Di'an Diagnostics Technology Co., Ltd, Kindstar Global, Siemens AG, LumiraDx Limited, TestLine Clinical Diagnostics s.r.o., Hologic, Meridian Bioscience, Abbott Laboratories Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc

38. Global Tuberculosis Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Tuberculosis Diagnostics Market

40. Tuberculosis Diagnostics Market High Potential Countries, Segments and Strategies

  • 40.1 Tuberculosis Diagnostics Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Tuberculosis Diagnostics Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Tuberculosis Diagnostics Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer